Friday, DUSA Pharmaceuticals Inc. (DUSA) said its third-quarter GAAP net loss narrowed to $0.4 million or $0.02 per share from $2.8 million or $0.12 per share in the prior year period.
Non-GAAP net loss for the quarter, was $0.2 million or $0.01 per share narrower than $1.6 million or $0.07 per common share in the year-ago period.
Product revenues for the quarter rose to $6.93 million from $5.72 million in the comparable period.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.